Low-Grade Prostate Cancer: Time to Stop Calling It Cancer.

Eggener, Scott E; Berlin, Alejandro; Vickers, Andrew J; Paner, Gladell P; Wolinsky, Howard; Cooperberg, Matthew R

Eggener, Scott E; Berlin, Alejandro; Vickers, Andrew J; Paner, Gladell P; Wolinsky, Howard; Cooperberg, Matthew R.

Afiliação

Eggener SE; Section of Urology, University of Chicago, Chicago, IL.
Berlin A; Department of Radiation Oncology, University of Toronto, Toronto, Canada.
Vickers AJ; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY.
Paner GP; Department of Pathology, University of Chicago, Chicago, IL.
Wolinsky H; Patient-Advocate, Answer Cancer Foundation, Chicago, IL.
Cooperberg MR; Department of Urology, University of California-San Francisco, San Francisco, CA.

J Clin Oncol ; 40(27): 3110-3114, 2022 09 20.

Article em En | MEDLINE | ID: mdl-35436144

Assuntos

Próstata; Neoplasias da Próstata; Humanos; Masculino; Gradação de Tumores; Antígeno Prostático Específico; Neoplasias da Próstata/terapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata Limite: Humans / Male Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google